Drug Company Gilead Gives $11M To Halt Hep C Rise In Ohio Valley

By: Lisa Gillespie | Ohio Valley ReSource
Posted on: Friday, April 26, 2019

Drug maker Gilead Sciences will give $11.3 million to help prevent and treat hepatitis C in Kentucky, Indiana, West Virginia, Tennessee and North Carolina. That money is part of a five-year project aimed at a region that’s been hit hard by the viral disease. About 43,000 people in Kentucky have hepatitis C, according to recent estimates from Emory University. A 2017 report showed… Read More